Article Sidebar

PDF
Date Published: 02/06/2025
Abstract Views: 38
Views PDF: 29
DOI: 10.60137/tmhvn.v70i69.213
Issue
Vol. 70 No. 69
Section
Articles
How to Cite
Le, T. H., Nguyen, T. K. V., Tong, X. T., Dao, T. D., & Cam, B. T. (2025). BACTERIOLOGY AND ANTIMICROBIAL SUSCEPTIBILITY IN CHILDREN CHRONIC SINUSITIS. Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery, 70(69), 55-61. https://doi.org/10.60137/tmhvn.v70i69.213

BACTERIOLOGY AND ANTIMICROBIAL SUSCEPTIBILITY IN CHILDREN CHRONIC SINUSITIS

Thi Huong Le1, , Thi Khanh Van Nguyen2, Xuan Thang Tong3, Trung Dung Dao3, Ba Thuc Cam4
1 Phân hiệu đại học Y Hà Nội tại Thanh Hoá
2 Bệnh viện Tai Mũi Họng Trung ương
3 Đại học Y Hà Nội
4 Bệnh viện Phục Hồi Chức năng Trung Ương, Phân hiệu Đại học Y Hà Nội tại Thanh Hóa

Main Article Content

Abstract

Objective: Bacteriological findings and antimicrobial susceptibility in children chronic sinusitis   Methods: Prospective cross- sectional study on 47 patients from age 5-15 years who have been diagnosed chronic rhinosinusitis at the National Otorhinolaryngology Hospital 9/ 2018 - 7/2019. Results: Anaerobic bacteria culture positive rate 66%, 8 bacterial species were isolated. Common bacteria:S.aureus 45.1%, S.epidermis 19.3%, HI 19.3%. Heamophilus influenzae 18,2%. Prevalence MRSA was hight in 78,6%. Antibiotic groups with high sensitivity include Quinolone (92.9-100%), Linezolid (100%) Amikacin (100%) Cephalosporin 4 (Cefepime 100%) Vancomycin (100%). Ampicillin is less sensitive to bacteria (sensitive 0-17%). Betalactamase-resistant derivatives are 50-100% sensitive but completely resistant to staphylococci (0% sensitive). Cephalosporin 2,3 is highly sensitive to bacteria except S.aureus and S.epidermis (sensitivity is only 14.3-33.3%). Conclusion:. S.aureus, S.epidermis and HI were the most prevalent pathogens. MRSA was hight prevalence. Antibiotic high sensitivity include Quinolone, Linezolid, Amikacin, Cephalosporin 4, Vancomycin.

Keywords

children chronic sinusitis, bacteria, Antibiogram, antibiotic sensitivity

Article Details

References

1. Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. doi:10.4193/Rhin20.600
2. Adams PF, Hendershot GE, Marano MA, Centers for Disease Control and Prevention/National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10. 1999;(200):1-203.
3. Kay DJ, Rosenfeld RM. Quality of Life for Children with Persistent Sinonasal Symptoms. Otolaryngol Head Neck Surg. 2003;128(1):17-26. doi:10.1067/mhn.2003.41
4. Cunningham MJ, Chiu EJ, Landgraf JM, Gliklich RE. The health impact of chronic recurrent rhinosinusitis in children. Archives of otolaryngology–head & neck surgery. 2000;126(11):1363-1368. doi:10.1001/archotol.126.11.1363
5. Hsin CH, Su MC, Tsao CH, Chuang CY, Liu CM. Bacteriology and antimicrobial susceptibility of pediatric chronic rhinosinusitis: a 6-year result of maxillary sinus punctures. American Journal of Otolaryngology. 2010;31(3):145-149. doi:10.1016/j.amjoto.2008.11.014
6. Mary Anne Jackson MD, Jennifer Goldman MD. AAP report details use of fluoroquinolones in children. Published online October 31, 2016. Accessed May 8, 2024. https://publications.aap.org/aapnews/news/7040/AAP-report-details-use-of-fluoroquinolones-in
7. Chandy Z, Ference E, Lee JT. Clinical Guidelines on Chronic Rhinosinusitis in Children. Curr Allergy Asthma Rep. 2019;19(2):14. doi:10.1007/s11882-019-0845-7
8. Beswick DM, Messner AH, Hwang PH. Pediatric Chronic Rhinosinusitis Management in Rhinologists and Pediatric Otolaryngologists. Ann Otol Rhinol Laryngol. 2017;126(9):634-639. doi:10.1177/0003489417719717
9. Chandy Z, Ference E, Lee JT. Clinical Guidelines on Chronic Rhinosinusitis in Children. Curr Allergy Asthma Rep. 2019;19(2):14. doi:10.1007/s11882-019-0845-7